Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri D'Alessandra

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Current Opinion in Cardiology|April 6, 2012
MicroRNAs and myocardial infarctionYuri D'Alessandra, Giulio Pompilio, Maurizio C Capogrossi
Current Vascular Pharmacology|May 30, 2013
microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial IschemiaPasquale Fasanaro, Yuri D'Alessandra, Alessandra Magenta, et al.
Heart Failure Reviews|September 26, 2017
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patientsClarissa Ruggeri, Sonia Gioffré, Felice Achilli, et al.
International Journal of Molecular Sciences|December 1, 2020
Circulating 16S RNA in Biofluids: Extracellular Vesicles as Mirrors of Human Microbiome?Veronica Ricci, Davide Carcione, Simone Messina, et al.
Cells|August 8, 2014
microRNAs and Cardiac Cell FateChiara Piubelli, Viviana Meraviglia, Giulio Pompilio, et al.
Heart Rhythm|September 30, 2018
Arrhythmogenic cardiomyopathy: what blood can reveal?Ilaria Stadiotti, Giulio Pompilio, Angela Serena Maione, et al.
RNA Biology|September 26, 2018
Direct screening of plasma circulating microRNAsPaola Songia, Mattia Chiesa, Vincenza Valerio, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2004
The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugationPamela Ghioni, Yuri D'Alessandra, Gelsomina Mansueto, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase InhibitorEmily Borretto, Loretta Lazzarato, Francesco Spallotta, et al.
Cell Cycle (Georgetown, Tex.)|August 26, 2006
Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutantsMauro Lanza, Barbara Marinari, Marina Papoutsaki, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Opinion in Cardiology|April 6, 2012
MicroRNAs and myocardial infarctionYuri D'Alessandra, Giulio Pompilio, Maurizio C Capogrossi
Current Vascular Pharmacology|May 30, 2013
microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial IschemiaPasquale Fasanaro, Yuri D'Alessandra, Alessandra Magenta, et al.
Heart Failure Reviews|September 26, 2017
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patientsClarissa Ruggeri, Sonia Gioffré, Felice Achilli, et al.
International Journal of Molecular Sciences|December 1, 2020
Circulating 16S RNA in Biofluids: Extracellular Vesicles as Mirrors of Human Microbiome?Veronica Ricci, Davide Carcione, Simone Messina, et al.
Cells|August 8, 2014
microRNAs and Cardiac Cell FateChiara Piubelli, Viviana Meraviglia, Giulio Pompilio, et al.
Heart Rhythm|September 30, 2018
Arrhythmogenic cardiomyopathy: what blood can reveal?Ilaria Stadiotti, Giulio Pompilio, Angela Serena Maione, et al.
RNA Biology|September 26, 2018
Direct screening of plasma circulating microRNAsPaola Songia, Mattia Chiesa, Vincenza Valerio, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2004
The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugationPamela Ghioni, Yuri D'Alessandra, Gelsomina Mansueto, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase InhibitorEmily Borretto, Loretta Lazzarato, Francesco Spallotta, et al.
Cell Cycle (Georgetown, Tex.)|August 26, 2006
Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutantsMauro Lanza, Barbara Marinari, Marina Papoutsaki, et al.
Pageof 4